Adam Rocker
NIH Rank #40026
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15605369Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$325K
Full award amounts, FY2024
Award Records
1
Records listing this PI
Award-Linked Rank
#40,026
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2024): $325K in linked award amounts across 1 award record · Award-linked rank #40026.
FY2024 award records by amount
NIH award records listing Adam Rocker as a PI. Multi-PI records show the full award amount for context.
- 1R43DK141293-01R43Advancing Diabetic Foot Ulcer Treatment with Provasliex, a Controlled PDGF Release Hydrogel for Promoting Vascularization and Managing Overactive Inflammation$325Kaward amount
Award organization
Organizations that administered FY2024 awards listing Adam Rocker as a PI.
FY2024 award administered by Gelsana Therapeutics, Inc. (CO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024ScienceDex Coverage BeginsEarliest loaded PI award records: FY2024